Matches in SemOpenAlex for { <https://semopenalex.org/work/W3149641377> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3149641377 endingPage "13" @default.
- W3149641377 startingPage "8" @default.
- W3149641377 abstract "Aim. To study the efficiency of IL-6 inhibitor olokizumab in suppressing the inflammation and improving treatment outcomes in patients with moderate COVID-19 pneumonia. Materials and Methods. We enrolled 48 patients with confirmed COVID-19 pneumonia who had indications for the treatment with olokizumab. Treatment group (n = 29) included patients who received a single subcutaneous injection of olokizumab (0.4 mL, 160 mg/mL) while placebo group (n = 19) included those who did not receive the drug because of contraindications. Inflammatory markers (C-reactive protein, white blood cell count, lymphocyte count, ferritin and D-dimer) have been evaluated on the 1st and the 5th day after the administration of olokizumab. Efficiency of olokizumab was assessed by the treatment outcome and suppression of cytokine storm. Results. At the 5th day, SpO2 was 90% (88; 92-93) in both groups, yet none of the patients in the treatment group required a mechanical ventilation, in contrast to 21.1% patients in the placebo group (p = 0.001). Inflammatory parameters were also reduced in the treatment group according to the measurements of serum C-reactive protein (5.6 (1.8;13.5) and 23 (17;92.5) mg/L in the treatment and placebo group, respectively, p = 0.0002) and white blood cell count (5.9 (4.8;6.2) and 7.6 (6.6;12 )*109 /L in the treatment and placebo group, respectively, p=0.03). No statistically significant differences were registered regarding serum ferritin (325 (200; 700) and 215 (186; 526) ng/mL, p = 0.41), D-dimer (827 (378; 1940) and 1464 (677; 4600) ng FEU/mL, p = 0.16) and lymphocyte count (1.3 (0.8; 2.1) and 1.5 (1; 2.1)*109 /L, p =0.44). Death was registered in 3.5% and 21.1% of patients in the treatment and placebo group, respectively, (p = 0.05). Conclusion. Olokizumab ameliorated the progression of COVID-19 pneumonia, improved treatment outcomes and reduced systemic inflammation." @default.
- W3149641377 created "2021-04-13" @default.
- W3149641377 creator A5003036923 @default.
- W3149641377 creator A5005343484 @default.
- W3149641377 creator A5037021912 @default.
- W3149641377 creator A5055686467 @default.
- W3149641377 creator A5065776183 @default.
- W3149641377 creator A5076284897 @default.
- W3149641377 date "2020-12-25" @default.
- W3149641377 modified "2023-09-27" @default.
- W3149641377 title "Efficiency of il-6 inhibitor (olokizumab) in suppressing inflammation in patients with moderate COVID-19 pneumonia" @default.
- W3149641377 cites W2035886603 @default.
- W3149641377 cites W2051568739 @default.
- W3149641377 cites W2097446414 @default.
- W3149641377 cites W2105723189 @default.
- W3149641377 cites W3009983851 @default.
- W3149641377 cites W3013232676 @default.
- W3149641377 doi "https://doi.org/10.23946/2500-0764-2020-5-4-8-13" @default.
- W3149641377 hasPublicationYear "2020" @default.
- W3149641377 type Work @default.
- W3149641377 sameAs 3149641377 @default.
- W3149641377 citedByCount "4" @default.
- W3149641377 countsByYear W31496413772021 @default.
- W3149641377 countsByYear W31496413772022 @default.
- W3149641377 crossrefType "journal-article" @default.
- W3149641377 hasAuthorship W3149641377A5003036923 @default.
- W3149641377 hasAuthorship W3149641377A5005343484 @default.
- W3149641377 hasAuthorship W3149641377A5037021912 @default.
- W3149641377 hasAuthorship W3149641377A5055686467 @default.
- W3149641377 hasAuthorship W3149641377A5065776183 @default.
- W3149641377 hasAuthorship W3149641377A5076284897 @default.
- W3149641377 hasBestOaLocation W31496413771 @default.
- W3149641377 hasConcept C126322002 @default.
- W3149641377 hasConcept C142724271 @default.
- W3149641377 hasConcept C203014093 @default.
- W3149641377 hasConcept C204787440 @default.
- W3149641377 hasConcept C27081682 @default.
- W3149641377 hasConcept C2776914184 @default.
- W3149641377 hasConcept C2777761686 @default.
- W3149641377 hasConcept C2777914695 @default.
- W3149641377 hasConcept C2778319317 @default.
- W3149641377 hasConcept C2778488018 @default.
- W3149641377 hasConcept C2779519742 @default.
- W3149641377 hasConcept C2781195455 @default.
- W3149641377 hasConcept C71924100 @default.
- W3149641377 hasConcept C90924648 @default.
- W3149641377 hasConceptScore W3149641377C126322002 @default.
- W3149641377 hasConceptScore W3149641377C142724271 @default.
- W3149641377 hasConceptScore W3149641377C203014093 @default.
- W3149641377 hasConceptScore W3149641377C204787440 @default.
- W3149641377 hasConceptScore W3149641377C27081682 @default.
- W3149641377 hasConceptScore W3149641377C2776914184 @default.
- W3149641377 hasConceptScore W3149641377C2777761686 @default.
- W3149641377 hasConceptScore W3149641377C2777914695 @default.
- W3149641377 hasConceptScore W3149641377C2778319317 @default.
- W3149641377 hasConceptScore W3149641377C2778488018 @default.
- W3149641377 hasConceptScore W3149641377C2779519742 @default.
- W3149641377 hasConceptScore W3149641377C2781195455 @default.
- W3149641377 hasConceptScore W3149641377C71924100 @default.
- W3149641377 hasConceptScore W3149641377C90924648 @default.
- W3149641377 hasIssue "4" @default.
- W3149641377 hasLocation W31496413771 @default.
- W3149641377 hasOpenAccess W3149641377 @default.
- W3149641377 hasPrimaryLocation W31496413771 @default.
- W3149641377 hasRelatedWork W2350053147 @default.
- W3149641377 hasRelatedWork W2354294306 @default.
- W3149641377 hasRelatedWork W2364362829 @default.
- W3149641377 hasRelatedWork W2380715309 @default.
- W3149641377 hasRelatedWork W3030827925 @default.
- W3149641377 hasRelatedWork W3108869804 @default.
- W3149641377 hasRelatedWork W3149641377 @default.
- W3149641377 hasRelatedWork W3186978314 @default.
- W3149641377 hasRelatedWork W3215285039 @default.
- W3149641377 hasRelatedWork W3217188342 @default.
- W3149641377 hasVolume "5" @default.
- W3149641377 isParatext "false" @default.
- W3149641377 isRetracted "false" @default.
- W3149641377 magId "3149641377" @default.
- W3149641377 workType "article" @default.